{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T22:39:16Z","timestamp":1783982356655,"version":"3.55.0"},"reference-count":38,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2023,6,14]],"date-time":"2023-06-14T00:00:00Z","timestamp":1686700800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Increasing evidence argues for the promotion of tumorigenesis through activation of the renin-angiotensin system pathway. Accordingly, a benefit of renin-angiotensin system blockers (RABs) treatments has been suggested in patients with solid cancers in terms of survival. We aimed to evaluate in-ICU survival and one-year survival in cancer patients admitted to the ICU with respect to the use of RABs. We conducted a retrospective observational single-center study in a 24-bed medical ICU. We included all solid cancer patients (age \u2265 18 years) requiring unplanned ICU admission. From 2007 to 2020, 1845 patients with solid malignancies were admitted (median age 67 years (59\u201375), males 61.7%). The most frequent primary tumor sites were the gastrointestinal tract (26.8%), the lung (24.7%), the urological tract (20.1%), and gynecologic and breast cancers (13.9%). RABs were used in 414 patients, distributed into 220 (53.1%) with angiotensin-receptor blockers (ARBs) and 194 (46.9%) with angiotensin-converting enzyme inhibitors (ACEis). After multivariate adjustment, ARBs use (OR = 0.62, 95%CI (0.40\u20130.92), p = 0.03) and ACEis use (OR = 0.52, 95%CI (0.32\u20130.82), p = 0.006) were both associated with improved in-ICU survival. Treatment with ARBs was independently associated with decreased one-year mortality (OR = 0.6, 95%CI (0.4\u20130.9), p = 0.02), whereas treatment with ACEis was not. In conclusion, this study argues for a beneficial impact of RABs use on the prognosis of critically ill cancer patients.<\/jats:p>","DOI":"10.3390\/cancers15123183","type":"journal-article","created":{"date-parts":[[2023,6,15]],"date-time":"2023-06-15T02:03:19Z","timestamp":1686794599000},"page":"3183","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Survival Benefit of Renin-Angiotensin System Blockers in Critically Ill Cancer Patients: A Retrospective Study"],"prefix":"10.3390","volume":"15","author":[{"given":"Driss","family":"Laghlam","sequence":"first","affiliation":[{"name":"Service de M\u00e9decine Intensive-R\u00e9animation, H\u00f4pital Cochin, Assistance Publique-H\u00f4pitaux de Paris (AP-HP), Centre\u2014Universit\u00e9 Paris Cit\u00e9, 75014 Paris, France"},{"name":"Universit\u00e9 Paris Cit\u00e9, 75014 Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anis","family":"Chaba","sequence":"additional","affiliation":[{"name":"Service de M\u00e9decine Intensive-R\u00e9animation, H\u00f4pital Cochin, Assistance Publique-H\u00f4pitaux de Paris (AP-HP), Centre\u2014Universit\u00e9 Paris Cit\u00e9, 75014 Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Tarneaud","sequence":"additional","affiliation":[{"name":"Service de M\u00e9decine Intensive-R\u00e9animation, H\u00f4pital Cochin, Assistance Publique-H\u00f4pitaux de Paris (AP-HP), Centre\u2014Universit\u00e9 Paris Cit\u00e9, 75014 Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3117-1235","authenticated-orcid":false,"given":"Julien","family":"Charpentier","sequence":"additional","affiliation":[{"name":"Service de M\u00e9decine Intensive-R\u00e9animation, H\u00f4pital Cochin, Assistance Publique-H\u00f4pitaux de Paris (AP-HP), Centre\u2014Universit\u00e9 Paris Cit\u00e9, 75014 Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Paul","family":"Mira","sequence":"additional","affiliation":[{"name":"Service de M\u00e9decine Intensive-R\u00e9animation, H\u00f4pital Cochin, Assistance Publique-H\u00f4pitaux de Paris (AP-HP), Centre\u2014Universit\u00e9 Paris Cit\u00e9, 75014 Paris, France"},{"name":"Universit\u00e9 Paris Cit\u00e9, 75014 Paris, France"},{"name":"Inserm U1016, CNRS UMR8104, Institut Cochin, 75014 Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"P\u00e8ne","sequence":"additional","affiliation":[{"name":"Service de M\u00e9decine Intensive-R\u00e9animation, H\u00f4pital Cochin, Assistance Publique-H\u00f4pitaux de Paris (AP-HP), Centre\u2014Universit\u00e9 Paris Cit\u00e9, 75014 Paris, France"},{"name":"Universit\u00e9 Paris Cit\u00e9, 75014 Paris, France"},{"name":"Inserm U1016, CNRS UMR8104, Institut Cochin, 75014 Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6966-5268","authenticated-orcid":false,"given":"Clara","family":"Vigneron","sequence":"additional","affiliation":[{"name":"Service de M\u00e9decine Intensive-R\u00e9animation, H\u00f4pital Cochin, Assistance Publique-H\u00f4pitaux de Paris (AP-HP), Centre\u2014Universit\u00e9 Paris Cit\u00e9, 75014 Paris, France"},{"name":"Universit\u00e9 Paris Cit\u00e9, 75014 Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,6,14]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/SHK.0000000000001524","article-title":"Hemodynamic Impact of Cardiovascular Antihypertensive Medications in Patients with Sepsis-Related Acute Circulatory Failure","volume":"54","author":"Jamme","year":"2020","journal-title":"Shock"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1620\/tjem.238.17","article-title":"Renin-Angiotensin-Aldosterone System Blockade in Critically Ill Patients Is Associated with Increased Risk for Acute Kidney Injury","volume":"238","author":"Lim","year":"2016","journal-title":"Tohoku J. Exp. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s40620-019-00603-4","article-title":"Angiotensin-Converting Enzyme Inhibitor\/Angiotensin II Receptor Blocker Use Prior to Medical Intensive Care Unit Admission and in-Hospital Mortality: Propensity Score-Matched Cohort Study","volume":"32","author":"Kobayashi","year":"2019","journal-title":"J. Nephrol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1097\/SHK.0000000000001382","article-title":"Preadmission Antihypertensive Drug Use and Sepsis Outcome: Impact of Angiotensin-Converting Enzyme Inhibitors (ACEIs) and Angiotensin Receptor Blockers (ARBs)","volume":"53","author":"Hsieh","year":"2020","journal-title":"Shock"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"On Behalf of FROG-ICU Investigators, Gayat, E., Hollinger, A., Cariou, A., Deye, N., Vieillard-Baron, A., Jaber, S., Chousterman, B.G., Lu, Q., and Laterre, P.F. (2018). Impact of Angiotensin-Converting Enzyme Inhibitors or Receptor Blockers on Post-ICU Discharge Outcome in Patients with Acute Kidney Injury. Intensive Care Med., 44, 598\u2013605.","DOI":"10.1007\/s00134-018-5160-6"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"e022870","DOI":"10.1161\/JAHA.121.022870","article-title":"Effects of Renin-Angiotensin\u2013Aldosterone System Inhibitors on Long-Term Major Adverse Cardiovascular Events in Sepsis Survivors","volume":"10","author":"Ou","year":"2021","journal-title":"JAHA"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1513\/AnnalsATS.202207-615OC","article-title":"Renin-Angiotensin System Inhibitors and Major Cardiovascular Events after Sepsis","volume":"20","author":"Angriman","year":"2023","journal-title":"Ann. Am. Thorac. Soc."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Laghlam, D., Jozwiak, M., and Nguyen, L.S. (2021). Renin\u2013Angiotensin\u2013Aldosterone System and Immunomodulation: A State-of-the-Art Review. Cells, 10.","DOI":"10.3390\/cells10071767"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"R15","DOI":"10.1186\/cc7713","article-title":"Characteristics and Outcomes of Cancer Patients in European ICUs","volume":"13","author":"Taccone","year":"2009","journal-title":"Crit. Care"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/S2213-2600(14)70061-X","article-title":"Assessment of the Worldwide Burden of Critical Illness: The Intensive Care Over Nations (ICON) Audit","volume":"2","author":"Vincent","year":"2014","journal-title":"Lancet Respir. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21708","article-title":"Cancer Statistics","volume":"72","author":"Siegel","year":"2022","journal-title":"CA Cancer J. Clin."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ijcard.2019.01.082","article-title":"Arterial Hypertension in Cancer: The Elephant in the Room","volume":"281","author":"Tini","year":"2019","journal-title":"Int. J. Cardiol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1001\/jama.291.20.2441","article-title":"Prognostic Importance of Comorbidity in a Hospital-Based Cancer Registry","volume":"291","author":"Piccirillo","year":"2004","journal-title":"JAMA"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1161\/HYPERTENSIONAHA.120.15026","article-title":"2020 International Society of Hypertension Global Hypertension Practice Guidelines","volume":"75","author":"Unger","year":"2020","journal-title":"Hypertension"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ejca.2021.12.024","article-title":"Renin\u2013Angiotensin\u2013Aldosterone System Inhibitors and Survival in Patients with Hypertension Treated with Immune Checkpoint Inhibitors","volume":"163","author":"Drobni","year":"2022","journal-title":"Eur. J. Cancer"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1002\/cncr.30079","article-title":"Increased Tumor Response to Neoadjuvant Therapy among Rectal Cancer Patients Taking Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers: ACEIs\/ARBs Affect Response in Rectal Cancer","volume":"122","author":"Morris","year":"2016","journal-title":"Cancer"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"4597","DOI":"10.21873\/anticanres.13639","article-title":"Renin\u2013Angiotensin Inhibition in Combating Malignancy: A Review","volume":"39","author":"Rosenthal","year":"2019","journal-title":"Anticancer. Res."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"3803","DOI":"10.1158\/1078-0432.CCR-18-0236","article-title":"Renin-Angiotensin System Inhibitors to Mitigate Cancer Treatment-Related Adverse Events","volume":"24","author":"Pinter","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s40959-019-0043-8","article-title":"Concomitant Use of Renin-Angiotensin-Aldosterone System Inhibitors Prevent Trastuzumab-Induced Cardiotoxicity in HER2+ Breast Cancer Patients: An Institutional Retrospective Study","volume":"5","author":"Moey","year":"2019","journal-title":"Cardio-Oncol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/BF01709751","article-title":"The SOFA (Sepsis-Related Organ Failure Assessment) Score to Describe Organ Dysfunction\/Failure. On Behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine","volume":"22","author":"Vincent","year":"1996","journal-title":"Intensive Care Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1001\/jama.1993.03510240069035","article-title":"A New Simplified Acute Physiology Score (SAPS II) Based on a European\/North American Multicenter Study","volume":"270","author":"Lemeshow","year":"1993","journal-title":"JAMA"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1186\/s13613-021-00968-5","article-title":"Patterns of ICU Admissions and Outcomes in Patients with Solid Malignancies over the Revolution of Cancer Treatment","volume":"11","author":"Vigneron","year":"2021","journal-title":"Ann. Intensive Care"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1007\/s00384-019-03379-y","article-title":"Angiotensin I-Converting Enzyme Inhibitors\/Angiotensin II Receptor Blockers May Reduce Tumor Recurrence in Left-Sided and Early Colorectal Cancers","volume":"34","author":"Ozawa","year":"2019","journal-title":"Int. J. Color. Dis."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1158\/1055-9965.EPI-20-0711","article-title":"Angiotensin Receptor Blockers Associated with Improved Breast Cancer Survival\u2014A Nationwide Cohort Study from Finland","volume":"29","author":"Santala","year":"2020","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1080\/21681805.2019.1634147","article-title":"Risk of Urothelial Cancer Death among People Using Antihypertensive Drugs-a Cohort Study from Finland","volume":"53","author":"Santala","year":"2019","journal-title":"Scand. J. Urol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"e19075","DOI":"10.1097\/MD.0000000000019075","article-title":"The Renin-Angiotensin System Blockers and Survival in Digestive System Malignancies: A Systematic Review and Meta-Analysis","volume":"99","author":"Zhou","year":"2020","journal-title":"Medicine"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1097\/CEJ.0000000000000269","article-title":"The Effect of Angiotensin System Inhibitors (Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers) on Cancer Recurrence and Survival: A Meta-Analysis","volume":"26","author":"Song","year":"2017","journal-title":"Eur. J. Cancer Prev."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/sj.bjc.6602961","article-title":"Angiotensin II Type 1 Receptor Expression in Ovarian Cancer and Its Correlation with Tumour Angiogenesis and Patient Survival","volume":"94","author":"Ino","year":"2006","journal-title":"Br. J. Cancer"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Acconcia, F. (2020). The Network of Angiotensin Receptors in Breast Cancer. Cells, 9.","DOI":"10.3390\/cells9061336"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.immuni.2012.10.015","article-title":"Angiotensin II Drives the Production of Tumor-Promoting Macrophages","volume":"38","author":"Etzrodt","year":"2013","journal-title":"Immunity"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"5959","DOI":"10.1158\/1078-0432.CCR-17-0256","article-title":"Use of Angiotensin System Inhibitors Is Associated with Immune Activation and Longer Survival in Non-Metastatic Pancreatic Ductal Adenocarcinoma","volume":"23","author":"Liu","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1073\/pnas.1818357116","article-title":"Losartan Treatment Enhances Chemotherapy Efficacy and Reduces Ascites in Ovarian Cancer Models by Normalizing the Tumor Stroma","volume":"116","author":"Zhao","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1016\/j.jacc.2019.03.495","article-title":"Randomized Trial of Lisinopril Versus Carvedilol to Prevent Trastuzumab Cardiotoxicity in Patients with Breast Cancer","volume":"73","author":"Guglin","year":"2019","journal-title":"J. Am. Coll Cardiol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1093\/eurheartj\/ehw022","article-title":"Prevention of Cardiac Dysfunction during Adjuvant Breast Cancer Therapy (PRADA): A 2 \u00d7 2 Factorial, Randomized, Placebo-Controlled, Double-Blind Clinical Trial of Candesartan and Metoprolol","volume":"37","author":"Gulati","year":"2016","journal-title":"Eur. Heart J."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"117181","DOI":"10.1016\/j.lfs.2019.117181","article-title":"Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers as Therapeutic Options in the Treatment of Renal Cancer: A Meta-Analysis","volume":"242","author":"Asgharzadeh","year":"2020","journal-title":"Life Sci."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"k4209","DOI":"10.1136\/bmj.k4209","article-title":"Angiotensin Converting Enzyme Inhibitors and Risk of Lung Cancer: Population Based Cohort Study","volume":"363","author":"Hicks","year":"2018","journal-title":"BMJ"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1183\/09031936.93.06040576","article-title":"Kinins and Respiratory Tract Diseases","volume":"6","author":"Trifilieff","year":"1993","journal-title":"Eur. Respir. J."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1007\/s00726-014-1736-9","article-title":"Involvement of Substance P and the NK-1 Receptor in Human Pathology","volume":"46","year":"2014","journal-title":"Amino Acids"}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/15\/12\/3183\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:54:40Z","timestamp":1760126080000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/15\/12\/3183"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,14]]},"references-count":38,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2023,6]]}},"alternative-id":["cancers15123183"],"URL":"https:\/\/doi.org\/10.3390\/cancers15123183","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,14]]}}}